ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,346.99
      -0.11%
      US Tech 100
      18,504.00
      -0.17%
      Dow Jones
      38,798.99
      -0.22%
      Brent Oil
      79.335
      -0.68%
      Bitcoin
      69,082.28
      -2.38%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Aquestive Therapeutics Inc (AQST)

      7. Aquestive Therapeutics Inc (AQST) News

      AQST

      Aquestive Therapeutics (AQST)

      Aquestive Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AQST
      DateTimeSourceHeadlineSymbolCompany
      2:15PMiHub NewswireFeaturedDaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio
      06/07/20248:13AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AQSTAquestive Therapeutics Inc
      06/06/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AQSTAquestive Therapeutics Inc
      06/03/20248:00AMGlobeNewswire Inc.Aquestive Therapeutics Announces Executive Appointments and Builds Commercial CapabilitiesNASDAQ:AQSTAquestive Therapeutics Inc
      05/28/20248:00AMGlobeNewswire Inc.Aquestive Therapeutics to Present Anaphylm™ (epinephrine) Sublingual Film Pharmacokinetic and Pharmacodynamic Data At 2024 Eastern Allergy ConferenceNASDAQ:AQSTAquestive Therapeutics Inc
      05/13/20241:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AQSTAquestive Therapeutics Inc
      05/13/20241:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AQSTAquestive Therapeutics Inc
      05/09/20248:00AMGlobeNewswire Inc.Aquestive Therapeutics to Participate in The Citizens JMP Life Sciences ConferenceNASDAQ:AQSTAquestive Therapeutics Inc
      05/07/20244:23PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AQSTAquestive Therapeutics Inc
      05/07/20244:21PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AQSTAquestive Therapeutics Inc
      05/07/20244:19PMGlobeNewswire Inc.Aquestive Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:AQSTAquestive Therapeutics Inc
      04/29/20247:00AMGlobeNewswire Inc.Aquestive Therapeutics Receives U.S. FDA Approval and Market Access for Libervant™ (diazepam) Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm™ (epinephrine) Sublingual FilmNASDAQ:AQSTAquestive Therapeutics Inc
      04/25/20248:00AMGlobeNewswire Inc.Aquestive Therapeutics to Report First Quarter 2024 Financial Results and Recent Business Highlights on May 7 and Host Conference Call on May 8 at 8:00 a.m. ETNASDAQ:AQSTAquestive Therapeutics Inc
      04/12/20244:01PMGlobeNewswire Inc.Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of NeurologyNASDAQ:AQSTAquestive Therapeutics Inc
      04/01/20248:00AMGlobeNewswire Inc.Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech ExecutiveNASDAQ:AQSTAquestive Therapeutics Inc
      03/25/20248:00AMGlobeNewswire Inc.Aquestive Therapeutics Announces Closing of Underwritten Public Offering of Common StockNASDAQ:AQSTAquestive Therapeutics Inc
      03/19/20249:49PMGlobeNewswire Inc.Aquestive Therapeutics Announces Pricing of $75 Million Underwritten Public Offering of Common StockNASDAQ:AQSTAquestive Therapeutics Inc
      03/19/20244:01PMGlobeNewswire Inc.Aquestive Therapeutics Announces Proposed Public Offering of Common StockNASDAQ:AQSTAquestive Therapeutics Inc
      03/14/20245:23PMGlobeNewswire Inc.Aquestive Therapeutics Announces Pivotal Study for Anaphylm™ (epinephrine) Sublingual Film Successfully Meets Primary and Secondary Endpoints and Provides Clinical Development Update Following FDA MeetingNASDAQ:AQSTAquestive Therapeutics Inc
      03/11/202410:36AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AQSTAquestive Therapeutics Inc
      03/11/202410:36AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AQSTAquestive Therapeutics Inc
      03/11/202410:35AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AQSTAquestive Therapeutics Inc
      03/11/202410:35AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AQSTAquestive Therapeutics Inc
      03/11/202410:35AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AQSTAquestive Therapeutics Inc
      03/11/202410:35AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AQSTAquestive Therapeutics Inc
      03/11/202410:34AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AQSTAquestive Therapeutics Inc
      03/08/20244:14PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AQSTAquestive Therapeutics Inc
      03/05/20245:12PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:AQSTAquestive Therapeutics Inc
      03/05/20245:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:AQSTAquestive Therapeutics Inc
      03/05/20245:05PMGlobeNewswire Inc.Aquestive Therapeutics Reports Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:AQSTAquestive Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:AQST